Xuezhikang Therapy Increases miR-33 Expression in Patients with Low HDL-C Levels

Background. MicroRNA-33a and -b (miR-33a/b) have been revealed to be posttranscriptional regulators of HDL metabolism. Xuezhikang (XZK) is a marked natural HDL-raising polypill. We aim to evaluate the effects of XZK on the expression of circulating miR-33a/b in patients with low plasma HDL-C levels....

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Ruihua, Bai, Yongyi, Sun, Lan, Zheng, Jin, Zu, Mian, Du, Guanhua, Ye, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925606/
https://www.ncbi.nlm.nih.gov/pubmed/24591767
http://dx.doi.org/10.1155/2014/781780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925606/
https://www.ncbi.nlm.nih.gov/pubmed/24591767
http://dx.doi.org/10.1155/2014/781780

Ejemplares similares